Cosmetic Peptide Synthesis Market (2026-2031) - Rising Demand for Anti-Aging Skincare Drives Growth
Demand is rising for anti-aging, carrier and hair-care peptides, fueled by automated synthesis, AI design, K-beauty premiumization and Asia-Pacific expansion.
Dublin, Aug. 21, 2026 (GLOBE NEWSWIRE) -- The "Cosmetic Peptide Synthesis - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" report has been added to ResearchAndMarkets.com's offering.
Cosmetic Peptide Synthesis Market to Reach USD 337.09 Million by 2031 as Demand for Advanced Anti-Aging Actives Accelerates
The global cosmetic peptide synthesis market was valued at USD 247.53 million in 2025 and is projected to increase from USD 259.63 million in 2026 to USD 337.09 million by 2031. The market is expected to register a compound annual growth rate of 5.34% during the 2026-2031 forecast period. Growth is being supported by rising demand for biomimetic anti-aging ingredients, advances in peptide manufacturing technology, and the expanding use of peptides in premium skin care, hair care, brightening, and barrier-repair products.
Demand for Biomimetic Anti-Aging Peptides Drives Market Growth
Clinical evidence supporting peptide-based cosmetic ingredients continues to strengthen their position in anti-aging formulations. Palmitoyl pentapeptide-4 has demonstrated the potential to reduce wrinkle depth by up to 20% within 12 weeks while avoiding the irritation commonly associated with topical retinoids. Acetyl hexapeptide-8 remains popular in expression-line products because of its visible smoothing effects, while copper-GHK peptides are gaining attention for supporting extracellular matrix remodeling and improving dermal density.
Beauty brands are increasingly combining signal, carrier, and enzyme-inhibitor peptides in multi-active formulations designed to provide complementary skin benefits. Although this strategy creates additional stability-testing requirements, it allows manufacturers to differentiate premium products and address multiple signs of skin aging. Peptides generally remain regulated as cosmetic ingredients unless product claims cross applicable therapeutic thresholds.
Automated Peptide Synthesis Expands Commercial Accessibility
Technological improvements in solid-phase peptide synthesis are reducing production time, labor requirements, and solvent consumption. Microwave-assisted reactors can shorten coupling times from hours to minutes, while continuous-flow systems may reduce solvent demand by approximately 40%. These advances enable contract manufacturers to deliver sub-kilogram custom peptide batches in as little as four weeks.
Lower production costs are also helping peptide actives move beyond luxury cosmetics and into mid-tier products priced below USD 50. Meanwhile, ISO 22716 manufacturing practices support product traceability, quality control, and contamination management as output increases. Artificial intelligence-driven peptide sequence design is further shortening research and development cycles, although purification expenses continue to limit broader mass-market adoption.
South Korean Peptide Serums Strengthen Premium Beauty Trends
South Korean beauty companies are accelerating the premiumization of peptide skin care through serums that combine multi-functional peptides with ingredients such as PDRN. Many of these products retail above USD 80 per 30 mL and emphasize fermentation-derived sequences that align with clean-beauty positioning. Growing exports to North America and Europe indicate that premium Korean peptide formulations are gaining traction outside Asia.
Signal Peptides Lead While Carrier Peptides Gain Momentum
Signal peptides accounted for 41.82% of the cosmetic peptide synthesis market in 2025. Demand remains supported by the established use of palmitoyl pentapeptide-4 and palmitoyl tripeptide-1 in anti-aging creams, as well as their predictable stability profiles and diversified supplier base.
Carrier peptides are forecast to record the fastest growth, with a 6.43% CAGR through 2031. Copper-GHK complexes are increasingly used to transport trace elements involved in extracellular matrix remodeling, helping formulators improve delivery performance and create differentiated product textures. Neurotransmitter-inhibitor peptides held a 23.1% market share in 2025, supported by their use in topical expression-line serums. Enzyme-inhibitor, antimicrobial, and pigment-modulating peptides are also expanding into products targeting pollution-related aging, acne, and hyperpigmentation.
Anti-Aging Remains the Largest Application
Anti-aging products represented 48.27% of the market in 2025. Multi-peptide formulations that support collagen production and address several visible signs of aging continue to sustain demand, even as growth moderates in mature markets.
Hair-care and scalp treatments are projected to expand at an 8.72% CAGR from 2026 to 2031. Research indicating that copper-GHK may prolong the follicle growth phase is encouraging cosmetic companies to extend peptide use beyond facial skin care. Whitening and brightening products held a 16.8% share, driven by ingredients such as oligopeptide-68 and nonapeptide-1. Barrier-repair creams and moisturizers accounted for 14.3%, while peptide applications in eye care, sun care, and after-sun recovery continue to develop.
North America Leads as Asia-Pacific Posts the Fastest Growth
North America held 42.84% of the global cosmetic peptide synthesis market in 2025. The region benefits from established manufacturing facilities, strong demand for high-purity ingredients, and the concentration of AI-driven peptide design companies in the United States. North America is forecast to grow at a 4.8% CAGR, with Canada benefiting from cross-border regulatory alignment and Mexico seeing increased demand through premium retail channels.
Europe remains an important market, led by Germany's manufacturing capabilities and France's luxury beauty sector. The United Kingdom, Italy, and Spain are also recording steady growth as peptide formulations gain favor in sensitive-skin products.
Asia-Pacific is projected to be the fastest-growing region, registering a 9.36% CAGR through 2031. China is expanding recombinant biosynthesis capacity, while South Korean brands continue to develop proprietary peptide ingredients. Japan's regulatory environment supports efficacy-based positioning for approved functional cosmetics. India and Southeast Asia are also experiencing strong growth, supported by higher discretionary spending and expanding premium beauty consumption.
Demand across the Middle East and Africa is supported by high beauty spending, tourism retail, and products targeting hyperpigmentation and sun damage, although local manufacturing remains limited. In South America, Brazil leads regional adoption as domestic brands add peptides to anti-aging products developed for sun-exposed climates. Argentina and Chile also present growth opportunities, despite import challenges associated with currency volatility.
Key Topics Covered:
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Demand for Biomimetic Anti-Aging Actives
4.2.2 Lower-Cost High-Throughput SPPS Automation
4.2.3 Premiumisation of K-Beauty Peptide Serums
4.2.4 Brand-Supplier Co-Development of "Signature" Peptides
4.2.5 AI-Driven Peptide Sequence Design Shortening R&D Cycles
4.2.6 Fast-Track Functional-Cosmetics Regulations
4.3 Market Restraints
4.3.1 High Purification Costs Curb Mass-Market Pricing
4.3.2 Batch-To-Batch Variability in Liquid-Phase Synthesis
4.3.3 Scrutiny of Micro-Plastic Carriers in Formulations
4.3.4 Consumer Sensitivity To "Synthetic-Sounding" INCI Names
4.4 Regulatory Landscape
4.5 Technological Outlook
4.6 Porter's Five Forces Analysis
4.6.1 Threat of New Entrants
4.6.2 Bargaining Power of Buyers
4.6.3 Bargaining Power of Suppliers
4.6.4 Threat of Substitute Products
4.6.5 Intensity of Competitive Rivalry
5 Market Size & Growth Forecasts
5.1 By Peptide Type
5.1.1 Signal Peptides
5.1.2 Neurotransmitter Inhibitor Peptides
5.1.3 Carrier Peptides
5.1.4 Enzyme Inhibitor Peptides
5.1.5 Other Functional Peptides
5.2 By Application
5.2.1 Anti-aging
5.2.2 Whitening & Brightening
5.2.3 Barrier Repair & Moisturising
5.2.4 Hair-care & Scalp Treatments
5.2.5 Eye-care Products
5.2.6 Sun-care & After-sun
5.3 By Synthesis Technique
5.3.1 Solid-Phase Peptide Synthesis (SPPS)
5.3.2 Liquid-Phase Peptide Synthesis (LPPS)
5.3.3 Hybrid / Fragment Condensation
5.3.4 Recombinant / Cell-free Biosynthesis
5.4 By Purity Grade
5.4.1 ? 98 % Cosmetic Grade
5.4.2 95 - 98 % Cosmetic Grade
5.4.3 < 95 % Industrial / R&D Grade
5.5 By End User
5.5.1 Pharmaceutical & Biotechnology Companies
5.5.2 Contract Manufacturing Organisations (CMOs)
5.5.3 Other End Users
5.6 By Geography
5.6.1 North America
5.6.1.1 United States
5.6.1.2 Canada
5.6.1.3 Mexico
5.6.2 Europe
5.6.2.1 Germany
5.6.2.2 United Kingdom
5.6.2.3 France
5.6.2.4 Italy
5.6.2.5 Spain
5.6.2.6 Rest of Europe
5.6.3 Asia-Pacific
5.6.3.1 China
5.6.3.2 Japan
5.6.3.3 India
5.6.3.4 Australia
5.6.3.5 South Korea
5.6.3.6 Rest of Asia-Pacific
5.6.4 Middle East & Africa
5.6.4.1 GCC
5.6.4.2 South Africa
5.6.4.3 Rest of Middle East & Africa
5.6.5 South America
5.6.5.1 Brazil
5.6.5.2 Argentina
5.6.5.3 Rest of South America
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as Available, Strategic Information, Market Rank/Share for Key Companies, Products & Services, and Recent Developments)
6.3.1 AAPPtec
6.3.2 Activotec
6.3.3 AmbioPharm
6.3.4 Ashland Inc.
6.3.5 Bachem Holding AG
6.3.6 BASF SE
6.3.7 Bio Basic Inc.
6.3.8 CEM Corporation
6.3.9 Creative Peptides
6.3.10 Croda International plc (Sederma)
6.3.11 CSBio Company Inc.
6.3.12 DSM-Firmenich (Pentapharm)
6.3.13 Evonik Industries AG
6.3.14 GenScript Biotech Corp.
6.3.15 Givaudan SA (Active Beauty)
6.3.16 Lubrizol Corporation
6.3.17 PolyPeptide Group
6.3.18 RS Synthesis LLC
6.3.19 Symrise AG
6.3.20 Shenzhen JYMed Technology
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-Need Assessment
For more information about this report visit https://www.researchandmarkets.com/r/5tg9bm
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
